Skip to main content
. 2020 Sep 6;12(9):2533. doi: 10.3390/cancers12092533

Figure 1.

Figure 1

Co-immunofluorescence and immunoblots for Thrombospondin-4 (THBS4) and Platelet-derived growth factor receptor β (PDGFRβ) in normal and tumor tissues of colon cancer patients. (A) Immunofluorescence with an anti-THBS4 antibody (green) and anti-PDGFRβ antibody (red) on normal (N) and tumor (T) tissues of colon cancer patients. Scale bars = 100 µm. (B) Western blot with anti-THBS4 and anti-PDGFRβ antibodies on normal and tumor tissues of colon cancer patients. * p < 0.05, compared with normal tissue, t-test.